Cover Image
close this bookTraditional Medicinal Plants (Dar Es Salaam University Press - Ministry of Health - Tanzania, 1991, 391 p.)
close this folderPART I: USE AND PROMOTION OF TRADITIONAL MEDICINAL PLANTS IN THE AFRICAN REGION
View the documentRegistration and utilization of herbal remedies in some countries of Eastearn, Central and Southern Africa
View the documentA report on the development of a traditional medicine for bronchial asthma
View the documentResume of current research in medicinal plants in Botswana
View the documentThe use of data from traditional medicine: Tunisian experience
View the documentChemical and pharmacological studies of marketed traditional drugs
View the documentResearch into medicinal plants: The Somali experience
View the documentEffect of nitrogen and phosphorus on the essential oil yield and quality of chamomile (Matricaria chamomilla L.) flowers
View the documentChemical characterization of pharmacologically active compounds from Synadenium pereskiifolium
View the documentAbietane diterpene quinones from lepechinia bullata
View the documentAntimicrobial activity of Tanzanian traditional medicinal plants
View the documentIdentification of clovanediol: A rare sesquiterpene from the stem bark of canella winterana L. (Canellaceae), using spectrophotometric methods
View the documentA comparative study of the traditional remedy ''Suma-kala'' and chloroquine as treatment for malaria in the rural areas
View the documentEthnobotany and conservation of medicinal plants
View the documentBiotransformation of hydroxyanthraquinone glycosides in Cassia species
View the documentLe médicament indigène Africaine: Sa standardisation et son évaluation dans le cadre de la politique des soins de santé primaires
View the documentChemical Evaluation of Tanzanian medicinal plants for the active constituents as a basis for the medicinal usefulness of the plants
View the documentEthnobotany and the medicinal plants of the Korup rainforest project area, Cameroon
View the documentSeaweeds in medicine and pharmacy: A global perspective
View the documentBiotechnology and medicinal plants
View the documentPhytochemical investigations of four medicinal plants of Malawi: What next?
View the documentThe chemistry and pharmacology of the essential oil from the leaves of Hyptis suaveolens (L) Point
View the documentSome CNS effects of Datura stramonium L (Solanaceae) in mice
View the documentDiscovery and development of drugs from natural sources
View the documentA Survey of medicinal plants in Tabora region, Tanzania
View the documentIntérêt pharmacognosique des plantes de la flore médicinale Rwandaise: valeur chimiotherapeutique de quelques plantes Rwandaise
View the documentA note on the utilization and commercialisation of traditional medicine
View the documentExperience on the use of Tanzanian medicinal plants for the last decade (1979-1989)
View the documentA comparison of the status of medicinal plants development in Africa with selected parts of the world
View the documentExpérience du Burkina Faso en matière de pharmacopeé traditionnelle
View the documentThe role and use of ethnomedical data in the research on traditional medicines and medicinal plants
View the documentTraditional medicinal plants: Our cultural heritage
View the documentThe use of traditional medicinal plants: The cultural context

The chemistry and pharmacology of the essential oil from the leaves of Hyptis suaveolens (L) Point

C.K. MUTAYABARWA,* S.C. CHHABRA,*
G.M.P. MWALUKO,** J. FULGENCE,** and W. MSANGI**

*Traditional Medicine Research Unit
** Department of Pharmacology
Muhimbili Medical Centre
P.O. Box 65001
Dar es Salaam, Tanzania

Introduction

The use of indigenous plants for medical purposes is one of the greatest heritage our community must be proud of and preserve. Through trial and error, our ancestors collected the knowledge of plants which they used for various reasons. They developed medicines to cure ailments, arrow poisons to paralyse animals and birds, made colours, for decorating ornaments and clothes, cosmetics, perfumes and made preservatives. The proper knowledge of the plants which are useful and authentic is left with old men and women who are just ending their life span, and a few are left. Unlike in other continents, the African herbal knowledge is non-documented, which is resulting into a gradual extinction of traditional methods of healing using herbs and natural salts. We are hereby calling scientists of all professions to come to the rescue of our culture which is useful to none, except ourselves. We won't go in detail mentioning specific drugs in the pharmaceutical shelves which are of plant origin, but it is estimated to be about 60%. We believe that the duty of experts involved in traditional medicine research is to provide scientific basis of the practices of our herbalists aimed at upgrading, improving or authenticating their practices, pointing out without fear, the bogus medicinemen and fake traditional healers and assure medical practitioners that, the drugs made from indigenous plants are as good as modern ones. Thus by doing this the scientific community shall be making a very useful contribution to therapeutic innovation in primary health care in Africa.

We shall now present our research results on one of the medicinal plants commonly found in Tanzania which is called Hyptis suaveolens.

The plant is a herb of about 60 - 90cm tall. It is widely distributed all over Tanzania (Watt and Brandwijk 1969) and it is known by different vernacular names; e.g. Mvumbasi (Swahili), Mkamba (Chagga) and Mwatabazimu (Haya) etc. The plant is used by traditional healers to treat epilepsy, febrile, convulsions and abdominal pains (direct communication with healers). It is also reported to cure parasitic cutaneous diseases and fungal infections.

Chemical analysis of the plant led to the isolation of L-sabinene, d-limonene, fenchone, a-terpinene and felandrene (Mukherje et al. 1964), as well as several triterpenic acids, such as ursolic acid (Misra et al. 1983), diterpenoids, such as suaveolic acid and suaveolol (Misra et al. 1981).

We have extracted the volatile oil from the leaves of Hyptis suaveolens and investigated its chemical nature and then determined the antiepileptic activity of the extract in experimental animals.

Methods

Extraction of the volatile oil

The oil was extracted from fresh leaves by steam distillation using a Cleavenger apparatus. Then the extract was dried using dried sodium sulphate. The oil had a specific gravity of 0.6554 and specific rotation of +0.50°, in chloroform. Twelve normal alkanes C9 to C20 were used as internal standards. Results are reported in Table 3.

Screening for anticonvulsant activity

The anticonvulsant activity of the oil was investigated in white albino mice of the genus Thaillers, weighing 20 - 30 g. The experiment consisted of three parts:

(i) Establishing the working dose of metrazol (Table 1).

(ii) Establishing the optimum working dose of the essential oil (Table 2).

(iii) Screening for the anticonvulsant activity of the essential oil as compared to phenobarbitone (Table 4).

Table 1: Establishing a Safe Working Dose for Metrazol

Mouse

Weight(g)

Time to convulse (Sec)

Time to Death (Sec)

Gr. Ia




1

24

-

-

2

26

-

-

3

27

-

-

4

28

-

-

5

25

-

-

6

27

-

-

Gr. IIb




1

29

445

-

2

25

120

-

3

27

161

-

4

28

132

-

5

25

170

-

6

26

170

-

Gr.IIIc




1

27

108

180 min lethal dose

2

27

92

106

3

26

60

200

4

28

75

150

5

29

105

-

6

28

100

160

aDose give = 50 mg/kg; bDose given = 60 mg/kg; cDose given = 70 mg/kg

Table 2: Establishment of the Safe Working Dose of the Essential Oil of Hyptis Suaveolens

Mouse

Dose of the Hyptis oil Ml/Kg.

Time to death (sec) and % mortality in brackets

Gr. I

1.0

700 (60)

Gr. II

0.9

3600 (10)

Gr. III

0.8

4800 (1)

Gr. IV

0.6

-

Gr. V

0.5

-

Gr. VI

0.4

-

Gr. VII

0.3

-

Gr. VIII

0.2

-

Gr. IX

0.1

-

Gr. X

0 (only archis oil)

-

*Average weight of the mice was 28 g.

Table 3. Identified Peaks With Retention Time, Kovat's Retention Indices, Area Percentage, and Identification

S. No.

Peak No (Min)

Retention (Time) Indices

Kovat’s retention

Percentage Identification composition

1.

14

14.259

916

0.026Eumene

2.

15

14.655

924

0.00915-methyl-3 heptanone

3.

17

15.531

939

1.6978Benzaldehyde

4.

18

16.238

952

0.0539 Camphene

5.

21

16.994

964

2.12952-Octanone

6.

22

17.226

968

0.0801Sabinene

7.

23

17.575

973

0.7877b-Pinene

8.

24

18.01

980

1.5211Octan-3-ol

9.

25

18.299

984

1.1144Myrcene

10.

26

19.485

1006

0.0711Phellandrene

11.

27

19.769

1006

1.0194Benzyl alcohol

12.

28

20.058

1011

1.00793-Carene

13.

29

20.298

1015

0.3210a-Terpinene

14.

30

20.474

1017

2.6766P-cumene

15.

35

24.02

1070

0.1067Methyl benzoate

16.

36

24.12

1071

0.1829Fenchone

17.

37

24.55

1077

9.9796Linolool oxide

18.

38

25.1

1084

0.6196Linalool

19.

41

26.69

1106

9.6622Fenchyl alcohol

20.

43

27.67

1120

0.0288Cresol

21.

44

28.31

1130

0.483Camphor

22.

45

28.71

1135

0.0223Benzyl acetate

23.

46

29.16

1142

0.0347Menthone

24.

47

30.01

1154

0.5535Borneol

25.

49

30.81

1164

0.626Menthol

26.

50

31.12

1168

0.7354Terpinene-4-ol

27.

51

31.82

1178

1.5883a-Terpeneol

28.

56

34.35

1121

0.0491Citronellol

29.

57

34.93

1220

0.0187Cinnamaldehyde

30.

58

35.56

1229

0.0018Piperitone

31.

59

35.95

1235

0.0065Geraniol

32.

60

36.23

1239

0.0054Linalyl acetate

33.

61

36.85

1247

0.0179Citral (trans)

34.

63

37.92

1262

0.0615Anethole

35.

65

38.55

1271

0.0020Bornyl acetate

36.

66

38.98

1276

0.0137Cinnamyl alcohol

37.

74

42.89

1332

0.0477Terpinyl acetate

38.

75

43.53

1341

0.2090Eugenol

39.

76

45.04

1363

0.0113Nerol acetate

40.

78

46.53

1398

0.0126Isoeugenol (cis)

41.

79

47.23

1398

0.1187a-Guaiene

42.

80

47.61

1398

0.0126b-Guaiene

43.

82

48.57

1413

0.0394 Longifelone

44.

83

48.95

1418

0.0245Isoeugenol (trans)

45.

84

49.59

1428

8.0610b-caryophyllene

46.

86

50.52

1443

0.0242b-Bulsesene

47.

87

50.86

1448

0.1643Aromadeodrene

48.

88

51.71

1461

0.5037Humulene

49.

89

52.23

1468

0.1324Alloaromadendrene

50.

90

52.86

1477

0.0244Guaia-3,7 diene

51.

92

53.8

1491

0.1424b-Bulnesene

52.

94

54.85

1507

0.0244a-Chigadmarene

53.

95

55.38

1515

0.1155Nerolidol (cis)

54.

99

57.61

1551

0.0820Nerolidol (trans)

55.

100

58.3

1562

0.0391Apitonene-1

56.

101

58.67

1568

0.0512Apitonene-2

57.

103

59.56

1582

0.4500Caryophyllene oxide

58.

114

65.59

1680

0.4990Farnesol (trans)

59.

116

67

1702

0.0308Farnesol (cis)

Table 4: Anticonvulsant Activity of Hyptis Oil as Compared to Phenobarbitone

Volatile oil 0.5 ml/kg body weight

= VO

Arachis oil added to 1.0 ml

= AO

Metrazol 70 mg/kg body weight

= Metrazol

Phenobarbitone 50m g/kg body weight

= (Pb)

-Ve Control AO + Metrazole

Test V.O. +MetrazoIe

+Ve control Pb +Metrazole

Mouse weight

Time to Conv.) (Min)

Time to Death (Min)

Mouse weight (g)

Time to conv. (Min)

Time to Death (Min)

Mouse weight (g)

Time to Conv. (Min)

Time to Death (Min)

A.









27

120

150

28

-

-

30

-

-

28

100

106

24

-

-

22

-

-

25

121

138

25

-

-

27

-

-

28

108

160

28

-

-

28

-

-

26

93

110

30

-

-

25

-

-

27

75

102

28

-

-

27

-

-

B.









25

100

145

25

-

-

25

-

-

25

75

132

29

-

-

28

-

-

28

82

102

22

-

-

27

-

-

29

61

121

27

-

-

26

-

-

25

99

150

26

-

-

29

-

-

26

102

200

25

-

-

25

-

-

C.









25

110

160

25

-

-

25

-

-

28

69

109

26

-

-

30

-

-

30

95

132

27

-

-

25

-

-

22

102

149

22

-

-

27

-

-

26

100

140

27

-

-

28

-

-

27

82

120

28

-

-

25

-

-

Metrazol (60 mg/kg body weight) is the maximum toxic dose which induced convulsions in mice with minimum mortality rate, whereas 70 mg/kg body weight is the minimum lethal dose causing 99% mortality of the mice. The volatile oil 0.5 ml/kg body weight injected intraperitoneally was safe to mice, but higher doses such as, 1 ml/kg body weight of the volatile oil caused 60% mortality; 0.9 ml/kg body weight caused 10% morality and 0.8 ml/kg body weight caused 1% mortality.

0.5 ml/kg body weight of the Hyptis oil gave 100% protection against metrazol (70 mg/kg) induced convulsions, which was equivalent to the protection offered by phenobarbitone (50 mg/kg).

Discussion

There has not been any report on the anticonvulsant activity of the volatile oil from the leaves of Hyptis suaveolens. The results of the present study show that the volatile oil offered protection against metrazol and induced epileptic convulsions. The results confirm the usage of the leaves by traditional healers in the management of epilepsy. The toxicity of the oil cannot be overlooked as it has high mortality in mice injected intraperitoneally in higher doses (above 0.5 ml/kg). However, since the oil has been used for a long time without any reported toxicity we would advise the traditional healers to continue administering the medicine on a first aid basis using natural methods.

References

Ahmed A. and B.N. Dhawan. (1960). Japanese Journal of Pharmacy, 19: 472

Misra, R.S, T.N. Singh, and J. Upadhyay. (1983). J. Nat. Prod., 44: 735 - 748. Mukherjee, K.S. and R.K.

Mukherjee. (1984) J. Nat. Prod., 42: 377 - 378.

Mwaiwu, J., and P. A. Khan. (1968). Anticonvulsant activity of volatile oil from Tetraleura tetrapera. Elsevier Scientific Publishers Ltd.

Swinyard, E.A. (1949). J. Ann Pharm. A. (Scientific Ed.), 38: 201.

Watt. J.M. and M.G. Brandwijk. (1962). Medicinal and poisonous plans of Southern and Eastern Africa. E and S Livingstone Ltd. Edinburgh and London.